Ursodeoxycholic acid reduces the systemic toxicity of 1, 2-dichloro, 4-nitrobenzene by stimulating hepatic glutathione S-transferase in mice
- 31 December 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 54 (14) , 983-989
- https://doi.org/10.1016/0024-3205(94)00500-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Immunomodulatory Effects of Ursodeoxycholic Acid on Immune ResponsesHepatology, 1992
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1991
- Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile saltsGastroenterology, 1991
- Hepatic injury induced by bile salts: Correlation between biochemical and morphological eventsHepatology, 1990
- Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytesHepatology, 1990
- Hepatic Expression of Class I and Class Ii Major Histocompatibility Complex Molecules in Primary Biliary Cirrhosis: Effect of Ursodeoxycholic AcidHepatology, 1990
- IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?The Lancet, 1987
- Tauroursodeoxycholate prevents taurocholate induced cholestasisLife Sciences, 1982
- URSODEOXYCHOLIC ACID TREATMENT OF GALLSTONESThe Lancet, 1977
- DISSOLUTION OF CHOLESTEROL GALLSTONES BY URSODEOXYCHOLIC ACIDThe Lancet, 1977